温泽声,陈国俊

肾细胞癌（RCC）作为常见恶性肿瘤，其预后受多种因素综合影响，包括肿瘤分期、分级、患者年龄、基因特征及免疫状态等。传统治疗方法因个体差异效果有限。精准医学的发展推动了个性化治疗策略的应用，通过基因检测、免疫标志物分析等手段，为患者制定精准的靶向与免疫治疗方案。研究表明，结合分子标志物、靶向治疗与免疫治疗的个性化方案可显著改善肾细胞癌患者的治疗效果与生存期，展现出广阔的应用前景。

肾细胞癌；个性化治疗；预后因素；精准医学；靶向治疗

[1] 薛琦,罗志嵘,郭煦妍,等.Xp11.2易位性肾细胞癌的诊断及治疗进展[J].检验医学与临床,2025,22(06):855-859. [2] 陈欣,段志国,郑福鑫,等.CircSDHC调节miR-195-5p/SEPT2轴对肾细胞癌细胞恶性生物行为的影响[J].中国老年学杂志, 2025,45(06):1471-1479. [3] 冯毅,钟海源,麦镨尹,等.基于CT影像组学鉴别多房囊性肾细胞癌和肾细胞癌囊性变的价值[J].临床泌尿外科杂志, 2025,40(03):263-269. [4] 赵厚铭,贾通宇,于淼,等.MRI影像组学对乳头状肾细胞癌WHO/ISUP分级的预测研究[J].微创泌尿外科杂志,2025,14(01):6-13. [5] 孙淼鑫,吴浩文,王鼎鼎,等.肾透明细胞癌合并磷脂酶A2受体相关膜性肾病3例及文献复习[J].临床肾脏病杂志, 2025,25(02):136-142. [6] 王喆,吕程程,刘溪,等.高危肾细胞癌术后辅助替雷利珠单抗治疗的临床疗效观察[J].临床泌尿外科杂志,2024,39(11):964-967+973. [7] 曾浩扬,杨焕程,刘伟豪,等.基于CT多维度解剖特征构建的肾细胞癌手术风险预测模型的研究[J].临床放射学杂志, 2024,43(11):1934-1939. [8] 张昆,王洋,王会剑,等.影像学检查在肉瘤样肾细胞癌诊断中的应用及进展[J].现代肿瘤医学,2024,32(21):4163-4166. [9] 李顺来,宋晓琳,周学玲,等.PRDM5通过Notch-1信号通路调控肾细胞癌增殖､侵袭及自噬的分子机制[J].中国老年学杂志, 2024,44(20):5074-5081. [10] 李逊佳,黎颖,刘承玄,等.中医药治疗肾细胞癌研究进展[J].中成药,2024,46(10):3364-3368. [11] Li K,Jia Z,Ren C,et al.In situ detection of renal cell carcinomas using diffuse reflectance and fluorescence spectroscopy for enhanced biopsy guidance:An ex vivo study[J].Optics and Laser Technology,2025,186112631-112631. [12] Sato T M,Yashima H,Araki T,et al.Effect of dasatinib on blood concentrations of sunitinib and adverse events in a patient with metastatic renal cell carcinoma treated with sunitinib:A case report.[J].Experimental and therapeutic medicine,2025,29(4):69. [13] Akkus E,Yekedüz E,Ürün Y.Sodium-Glucose Cotransporter 2(SGLT2)as a Potential Biomarker and Target in Papillary Renal Cell Carcinoma[J].Clinical Genitourinary Cancer,2025,23(2):102314-102314. [14] Lee F S,Harris N,Yip L P,et al.Utilization of a stabilized hyaluronic acid spacer in SBRT for retroperitoneal cancers:A case series and dosimetric analysis[J].Clinical and Translational Radiation Oncology,2025,52100943-100943. [15] McGregor A B,Xie W,Berg A S,et al.CDK4/6 Inhibition With Abemaciclib in Patients With Previously Treated Advanced Renal Cell Carcinoma[J].Clinical Genitourinary Cancer,2025,23(3):102318-102318. [16] Abdalla A B,Kakamad H F,Abdullah M A,et al.Pulmonary osseous metaplasia in association with renal cell carcinoma:A rare case report and literature review[J].Radiology Case Reports,2025,20(5):2328-2331. [17] Miyamoto A,Kuroda H,Yoshida R,et al.A case of multiple pancreatic metastases from renal cell carcinoma mimicking a neuroen- docrine tumor[J].Radiology Case Reports,2025,20(5):2544-2548. [18] Theparee T,Umetsu E S,Chan E.Pancreatic Serous Neoplasm and Metastatic Clear Cell Renal Cell Carcinoma:Diagnostic Pitfalls Resolvable by a Panel of Immunohistochemical Stains to Include PAX8 and CK7 But Not CAIX.[J].The American journal of surgical pathology,2025,49(4):394-402. [19] Aravind S,Sivasubramanian D,Sanil S,et al.Orbital metastasis of renal cell carcinoma masquerading as thyroid ophthalmopathy.[J]. Radiology case reports,2025,20(4):1812-1815. [20] VaicekauskaitėI,Žalimas A,SabaliauskaitėR,et al.Genomic analysis of small renal masses reveals mutations linked with renal cell carcinoma and fast-growing tumors[J].Journal of Cancer Research and Clinical Oncology,2025,151(3):118-118. [21] He S,Liu D,Chen J,et al.Liquid-based kidney injury molecule-1 as a diagnostic and prognostic indicator in renal cell carcinoma:A systematic review and meta-analysis[J].International Urology and Nephrology,2025,(prepublish):1-12. [22] Yang W,Wu C,Jiang C,et al.FDX1 overexpression inhibits the growth and metastasis of clear cell renal cell carcinoma by upregulating FMR1 expression[J].Cell Death Discovery,2025,11(1):115-115. [23] Zhang J,Liu G,Wang W.PRSS53 is a potential novel biomarker related to prognosis and immunity in clear cell renal cell carcinoma[J]. Discover Oncology,2025,16(1):362-362. [24] Ghadieh A,Khatib E K,Hamadeh G,et al.Incidental finding of probable epididymal adenomatoid tumor and tubulocystic renal cell carcinoma in a patient with epididymo-orchitis:a case report[J].Journal of Medical Case Reports,2025,19(1):130-130. [25] Shen T,Wang W,Wang H,et al.Mitochondrial miRNA miR-134-5p Play Oncogenic Role in Clear Cell Renal Cell Carcinoma[J]. Biomolecules,2025,15(3):445-445. [26] Mattke M,Schwaibold L,Krumm P,et al.[18F]SiTATE Uptake in a Pancreatic Metastasis From a Renal Cell Carcinoma on a Long Axial Field of View PET/CT.[J].Clinical nuclear medicine,2025.

点击下载PDF